Lexicon Pharmaceuticals, Inc. (LXRX)
1.80
-0.02
(-1.10%)
USD |
NASDAQ |
Nov 13, 16:00
1.80
0.00 (0.00%)
After-Hours: 19:59
Lexicon Pharmaceuticals Price to Book Value : 4.888 for Nov. 13, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 4.943 |
| November 11, 2026 | 5.079 |
| November 10, 2026 | 5.052 |
| November 09, 2026 | 4.943 |
| November 06, 2026 | 4.834 |
| November 05, 2026 | 4.372 |
| November 04, 2026 | 4.019 |
| November 03, 2026 | 3.965 |
| November 02, 2026 | 3.911 |
| October 30, 2026 | 3.856 |
| October 29, 2026 | 4.019 |
| October 28, 2026 | 4.033 |
| October 27, 2026 | 4.019 |
| October 26, 2026 | 3.938 |
| October 23, 2026 | 3.856 |
| October 22, 2026 | 4.047 |
| October 21, 2026 | 4.237 |
| October 20, 2026 | 4.291 |
| October 19, 2026 | 4.210 |
| October 16, 2026 | 4.128 |
| October 15, 2026 | 4.481 |
| October 14, 2026 | 4.345 |
| October 13, 2026 | 4.372 |
| October 12, 2026 | 4.481 |
| October 09, 2026 | 4.563 |
| Date | Value |
|---|---|
| October 08, 2026 | 4.780 |
| October 07, 2026 | 4.780 |
| October 06, 2026 | 4.753 |
| October 05, 2026 | 4.726 |
| October 02, 2026 | 4.943 |
| October 01, 2026 | 4.943 |
| September 30, 2026 | 5.092 |
| September 29, 2026 | 4.793 |
| September 28, 2026 | 4.844 |
| September 25, 2026 | 4.576 |
| September 24, 2026 | 4.742 |
| September 23, 2026 | 5.252 |
| September 22, 2026 | 5.558 |
| September 21, 2026 | 5.201 |
| September 18, 2026 | 5.226 |
| September 17, 2026 | 5.188 |
| September 16, 2026 | 5.150 |
| September 15, 2026 | 5.124 |
| September 14, 2026 | 5.048 |
| September 11, 2026 | 5.099 |
| September 10, 2026 | 5.150 |
| September 09, 2026 | 5.481 |
| September 08, 2026 | 5.685 |
| September 04, 2026 | 5.711 |
| September 03, 2026 | 5.762 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Bristol Myers Squibb Co. | 5.540 |
| ANI Pharmaceuticals, Inc. | 2.569 |
| Corcept Therapeutics, Inc. | 9.570 |
| Veru, Inc. | 1.274 |
| Johnson & Johnson | 8.444 |
Price to Book Value Related Metrics
| PS Ratio | 19.22 |
| Price | 1.80 |
| Earnings Yield | -8.30% |
| Market Cap | 800.96M |